Skip to main content

Table 3 Characteristics of primary malignant cardiac tumors

From: Primary cardiac tumors on the verge of oblivion: a European experience over 15 years

Histology and location No. of patients (% of malignant) Tumor relapse Distant metastasis Mean survival (months)
Malignant 11 (9.7%) 5 9 26.2 ± 9.8
Sarcoma (all), subtypes 10 (91.0%), subtypes: 5 8 21.1 ± 10.7
Angiosarcoma 3 (27.3%) 2 3 25.3 ± 17.6
right atrium     
Intima sarcoma*** 1 (9.1%) 0 1 1.0 ± 0.0
left atrium and anterior mitral valve leaflet, obstructive     
Spindle cell sarcoma 1 (9.1%) 1 0 7.0 ± 0.0
right atrium and SVC, completely obstructive     
Synovial sarcoma 1 (9.1%) 1 1 64.00 ± 0.0
right atrium/ventricle, obstructing SVC/IVC     
Pleomorphic sarcoma**** 1 (9.1%) 0 1 0.0 ± 0.0
left atrium, completely obstructive     
Myxofibrosarcoma 2 (18.2%) 0 1 7.0 ± 0.0
left atrium     
Myeloid sarcoma 1 (9.1%) 1 1  
right atrium, obstructing superior and inferior caval vein     
NHL (DLCBL)****** 1 (9.1%) 0 1  
right atrium and right ventricle, obstructive     
  1. Data presented as mean ± standard deviation, n (%) or mean (range). SVC, superior vana cava; IVC, inferior vena cava.
  2. ***Patient underwent cardial autotransplantation.
  3. ****Patient had a heart transplantation 8 years ealier. Obstructing sarcoma formation in the left atrium of the heart allograft.
  4. *****One Patient (0.9%) with left atrial myxoma had a tumor relapse as Myxofibrosarcoma 3 months upon surgery.
  5. ******NHL indicates Non Hodgkin Lymphoma of the Diffuse Large B-Cell Lymphpma type.